|
Oct 8
|
Commencement of trading on OTCQB in the United States
|
|
Jun 27
|
Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determination
|
|
May 15
|
Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024
|
|
May 9
|
Renalytix to Report Financial Results for Third Quarter Fiscal Year 2024 on May 15
|
|
Apr 8
|
Renalytix Announces Financing with Expected Size of up to $4 Million
|
|
Mar 25
|
3 Ridiculously Enticing Stocks to Buy for Under a Buck
|
|
Mar 14
|
KidneyIntelX™ included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease (CKD)
|
|
Jan 10
|
New published data demonstrates KidneyIntelX™ has broad implications for winning war on chronic kidney disease
|
|
Sep 7
|
Renalytix Appoints Senior Executive Howard Doran as Chief Business Officer
|